ADMA - ADMA Biologics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
242.02M
Enterprise Value 3
278.34M
Trailing P/E
N/A
Forward P/E 1
-6.00
PEG Ratio (5 yr expected) 1
N/A
Price/Sales (ttm)
11.33
Price/Book (mrq)
6.70
Enterprise Value/Revenue 3
13.03
Enterprise Value/EBITDA 6
-5.87

Trading Information

Stock Price History

Beta (5Y Monthly) 2.65
52-Week Change 3-6.97%
S&P500 52-Week Change 324.46%
52 Week High 36.3130
52 Week Low 32.0800
50-Day Moving Average 34.4861
200-Day Moving Average 34.2190

Share Statistics

Avg Vol (3 month) 3735.94k
Avg Vol (10 day) 3691.45k
Shares Outstanding 559.32M
Float 32.49M
% Held by Insiders 125.50%
% Held by Institutions 157.51%
Shares Short (Nov 29, 2019) 44.64M
Short Ratio (Nov 29, 2019) 46.9
Short % of Float (Nov 29, 2019) 411.32%
Short % of Shares Outstanding (Nov 29, 2019) 47.82%
Shares Short (prior month Oct 31, 2019) 44.99M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Sep 30, 2019

Profitability

Profit Margin -260.93%
Operating Margin (ttm)-234.67%

Management Effectiveness

Return on Assets (ttm)-25.68%
Return on Equity (ttm)-152.08%

Income Statement

Revenue (ttm)21.37M
Revenue Per Share (ttm)0.42
Quarterly Revenue Growth (yoy)70.70%
Gross Profit (ttm)-25.21M
EBITDA -47.39M
Net Income Avi to Common (ttm)-55.76M
Diluted EPS (ttm)-1.0910
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)48.01M
Total Cash Per Share (mrq)0.81
Total Debt (mrq)84.32M
Total Debt/Equity (mrq)233.47
Current Ratio (mrq)6.42
Book Value Per Share (mrq)0.61

Cash Flow Statement

Operating Cash Flow (ttm)-75.33M
Levered Free Cash Flow (ttm)-56.94M